Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Michael Saylor Hints at Next Bitcoin Buy Despite MicroStrategy’s Sharp Slowdown

Michael Saylor Hints at Next Bitcoin Buy Despite MicroStrategy’s Sharp Slowdown

BeInCryptoBeInCrypto2025/10/26 11:30
By:Oluwapelumi Adejumo

Strategy, formerly MicroStrategy, has slowed its Bitcoin purchases to the lowest level since 2020, acquiring only about 200 BTC weekly.

Strategy (formerly known as MicroStrategy), the largest corporate Bitcoin holder, is acquiring the top crypto at its slowest pace in recent memory.

Yet its executive chairman, Michael Saylor, continues to hint that another large-scale purchase may be on the horizon.

Strategy’s Bitcoin Buying Spree Significantly Slows

On October 26, CryptoQuant analyst J. Maartunn reported a sharp decline in Strategy’s weekly Bitcoin acquisitions.

According to him, the company’s purchases have fallen from tens of thousands of BTC per week in late 2024 to roughly 200 BTC in recent weeks.

For context, the company was buying more than 10,000 BTC in a single week, including a record surge of 55,500 BTC at its peak.

Michael Saylor Hints at Next Bitcoin Buy Despite MicroStrategy’s Sharp Slowdown image 0Strategy’s Bitcoin Purchases. Source: CryptoQuant

However, that figure has dwindled to a few hundred coins, the same level seen five years ago when the company was still testing its dollar-cost-averaging strategy.

Meanwhile, this slowdown signals not waning conviction, but tighter financial conditions that have constrained new capital deployment.

Strategy’s equity issuance premium, the gap between its share price and the book value of its Bitcoin holdings, has plunged from 208% to 4%.

That collapse has made new stock offerings a far less efficient way to raise capital for additional Bitcoin buys.

Michael Saylor Hints at Next Bitcoin Buy Despite MicroStrategy’s Sharp Slowdown image 1Startegy’s MSTR Premium. Source: CryptoQuant

At the same time, the company’s stock price has fallen roughly 50% from its record high, while Bitcoin trades about 16% below its $126,000 all-time peak, hovering near $111,000 as of press time.

These lower market valuations and thinner financing options have inadvertently forced Strategy to moderate its buying pace.

Saylor Hints at ‘Orange Dot Day’

Despite the slowdown, Saylor continues to signal that Bitcoin remains central to the company’s treasury strategy.

On X, he posted a screenshot of Strategy’s Bitcoin tracker alongside the phrase “It’s Orange Dot Day.” This is a cryptic cue he has used repeatedly ahead of official purchase announcements.

It's Orange Dot Day.

— Michael Saylor (@saylor) October 26, 2025

Notably, such posts often precede formal filings, suggesting that another buy could arrive soon.

However, even with reduced frequency, Strategy remains one of the most aggressive institutional accumulators in the market. The firm has spent roughly $19.5 billion on Bitcoin in 2025 alone, trailing only its $21.7 billion total from 2024.

Michael Saylor Hints at Next Bitcoin Buy Despite MicroStrategy’s Sharp Slowdown image 2Strategy’s Yearly USD Investments in Bitcoin. Source: CryptoQuant

These purchases have helped push Strategy holdings to 640,418 BTC, which equates to around 3.2% of all Bitcoin in circulation.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification

Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.

智通财经2026/09/21 11:06

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

智通财经2026/09/21 09:31
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

STONK hits new highs after erasing 27% crash

Cryptopolitan2026/09/21 09:30
STONK hits new highs after erasing 27% crash